Chinese Biotech Firm LianBio Prices US$325 Million Nasdaq IPO

Biotech company LianBio (Nasdaq: LIAN) started trading on the Nasdaq Global Market today. The Shanghai-based firm aims to raise approximately US$325 million in its debut on the US big board.

The offering consisted of 20,312,500 American depositary shares at US$16.00 per ADS, which represents 1 ordinary company share. The ADSs will be trading on the Nasdaq exchange under the symbol “LIAN”.

Goldman Sachs & Co., Jefferies, and BofA Securities, Inc. are acting as the joint bookrunners for the said offering. The underwriters were given a 30-day over-allotment option to purchase up to an additional 3,046,875 ADSs at the same IPO price.

The company also has its offices in Princeton, New Jersey. According to its website, the firm aims “to bring transformative medicines to historically underserved patients in China and other Asian markets.”


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Russell Will Lead the Next Market Crash!? | John Feneck

The Global Conflict Has Already Started | Bryan Cunningham

Silver Still At 90:1, What If It Snaps Back To 15:1? | Glenn Jessome – Silver Tiger

Recommended

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Altamira Gold Encounters Porphyritic Intrusive Rocks In Initial Scout Drilling At Regional Targets

Related News

Small-Cap IPOs That Are Pump-And-Dumps Are On The Rise, Thanks To Chinese Firms

The Financial Industry Regulatory Authority Inc. (FINRA) cautions that initial public offerings (IPOs) by international...

Saturday, November 19, 2022, 11:11:00 AM

Financial SPAC FG Acquisition Announces US$100 Million TSX IPO

Blank check firm FG Acquisition is looking to go public on the Toronto Stock Exchange....

Tuesday, March 22, 2022, 02:18:00 PM

Fintech Firm Blend Labs Seeks US$360 Million In IPO

Blend Labs Inc. announced this morning the launch of its initial public offering on the...

Tuesday, July 6, 2021, 11:20:00 AM

Healthcare SPAC Healthwell Acquisition Aims To Raise US$250 Million In IPO

Special purpose acquisition company Healthwell Acquisition Corp. I (NASDAQ: HWELU) went public on the Nasdaq...

Wednesday, August 4, 2021, 11:57:00 AM

Beverage Firm Westrock Coffee To Be Taken Public In A US$1.1 Billion SPAC Merger

Beverage brand Westrock Coffee Holdings entered into a definitive business combination agreement with special purpose...

Wednesday, April 6, 2022, 02:26:00 PM